Ascension Orthopedics Receives FDA Approval For PyroCarbon Foot Implant

Ascension Orthopedics, Inc.
announced today that it has received FDA approval on the first PyroCarbon
implant for the foot. The Ascension(R) PyroSphere(R) implant is designed
for the fourth and fifth tarsometatarsal joints of the foot and is intended
for people suffering from the debilitating effects of arthritis in the
foot.


"We are very pleased that the FDA has approved the PyroSphere(R) for
the lower extremity. We are looking forward to providing the benefits of
our implants to the foot and ankle surgeon," said Robert Martin, CEO of
Ascension Orthopedics.


The Ascension(R) PyroSphere(R) is a revolution in TMT arthroplasty
providing a new option to foot surgeons. The PyroSphere(R) is manufactured
from the patented material, On-X(R) Carbon, which offers characteristics
superior to those of other pyrocarbon material and is available only to
Ascension Orthopedics. The material has shown improved wear qualities
compared to other industry standard materials, thus enhancing the life of
the implant.


The Ascension(R) PyroSphere(R) is the first PyroCarbon implant to be
approved by the FDA in the lower extremity. This approval adds to the many
firsts for Ascension Orthopedics in the extremity market.


"Our goal is to provide our customer, the extremity surgeon, with new
and innovative solutions. Ascension will continue to lead the market in the
development of small joint implants and innovation in extremity surgery,"
adds Robert Martin.


The company has expanded its product platforms to include arthroplasty,
trauma, and tissue regeneration. Ascension currently offers more than ten
arthroplasty products, a complete elbow trauma set, and a tissue
regeneration portfolio that includes a nerve conduit and an adhesion
prevention product. The entry into the foot market for Ascension marks its
continued growth into the upper and lower extremity market.



Ascension Orthopedics, Inc.

ascensionortho